Shivlingeshwar College of Pharmacy, Almala, Latur, Maharashtra
Solid oral dosage forms, particularly tablets, remain the predominant choice in pharmaceutical therapy due to their ease of administration, patient acceptance, and cost-effectiveness. Nevertheless, the tablet manufacturing process is susceptible to various quality compromises that can arise from multifactorial origins including raw material characteristics, formulation composition, granulation methodology, and equipment performance. Contemporary pharmaceutical literature identifies a spectrum of defects—including surface separation phenomena (capping and lamination), structural integrity issues (cracking and chipping), adhesion-related complications (sticking, picking, and binding), appearance abnormalities (mottling), and impression irregularities—that can significantly impact product. The integration of preventive quality assurance mechanisms, adoption of continuous improvement methodologies, and implementation of rigorous environmental monitoring systems enables pharmaceutical manufacturers to substantially reduce batch-to-batch variability and achieve consistent product specifications. This synthesis of recent peer-reviewed literature underscores that successful tablet quality management requires coordinated optimization across formulation design, process execution, equipment utilization, and manufacturing infrastructure, thereby advancing both product excellence and regulatory compliance in the pharmaceutical industry.
Pharmaceutical tablets represent the most widely prescribed solid oral dosage form globally, accounting for over 70% of all medications dispensed due to their convenience, stability, patient compliance, and cost-effective Manufacturing. Despite significant technological advancements in tableting processes, manufacturing defects remain a persistent challenge that can compromise product quality, therapeutic efficacy, and patient safety. These defects may arise at various stages of production, ranging from formulation development and granulation to compression and coating processes.
The pharmaceutical industry continues to face multifaceted challenges in tablet manufacturing, with defects stemming from formulation issues, machine-related problems, environmental factors, and human errors. Recent years (2023-2025) have witnessed considerable research efforts focused on understanding the root causes of these defects and developing innovative solutions, including the integration of artificial intelligence and automated inspection systems for defect detection. This comprehensive review examines the most common tablet manufacturing defects encountered in pharmaceutical production, their underlying causes, and evidence-based remedies as reported in recent literature .
Classification of Tablet Defects :-
Tablet defects can be broadly classified into three major categories based on their origin.
Major Tablet Defects: Causes and Remedies
Definition: Capping is the partial or complete separation of the top or bottom portion of a tablet from the main body, occurring either during ejection from the die or during subsequent handling and coating operations.
Characterized by the partial or complete separation of the top or bottom portion of a tablet from its main body. This phenomenon usually occurs during the ejection of the tablet from the die or during subsequent handling and coating operations.
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
2. Lamination
Definition: Lamination refers to the horizontal separation of a tablet into two or more distinct layers, typically occurring during or immediately after Compression.
As a result, the tablet loses its structural integrity, leading to separation along planes parallel to its surface. Understanding lamination is important because it affects not only the tablet’s appearance and mechanical strength but also its uniformity and overall quality.
Causes:
Formulation-Related:
Machine-Related:
Machine Adjustments:
Remedies:
Formulation Approaches:
Machine Adjustments:
3. Sticking and Picking
Definition: Sticking occurs when tablet material adheres to the die wall or punch faces. Picking is a specific type of sticking where small amounts of material adhere to embossed letters, logos, or punch face engravings, creating pitted surfaces on tablets.
This adhesion happens because the particles of the tablet formulation bond to the metal surfaces, often due to factors such as moisture, inadequate lubrication, or rough tool surfaces.
Causes:
Formulation-Related:
Machine/Tooling-Related:
Remedies:
Formulation Approaches:
Tooling/Design Solutions:
4. Chipping
Definition: Chipping refers to the breaking or removal of tablet edges during ejection from the press, or during subsequent coating and handling operations.
Chipping is a tablet manufacturing defect characterized by the breaking or removal of small pieces from the edges of the tablet. This damage often occurs during the tablet’s ejection from the press or during subsequent processes such as coating and handling.
The causes of chipping include poor formulation factors like excessive or insufficient binding, overly dry granules which reduce plasticity, and mechanical issues such as worn or damaged punches and dies.
For example, worn die grooves or inward-turned punch edges can cause uneven compression, leading to cracks and chips on the tablet edges.
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
5. Cracking
Definition: Cracking manifests as fine fissures or cracks on the upper and lower central surfaces of tablets, or occasionally on the sidewalls
Cracking appears as fine fissures or cracks typically on the upper and lower central surfaces of tablets, and sometimes on the sidewalls. This defect is mainly caused by rapid expansion of tablets after compression, often due to the use of very dry granules, improper binder content, or excessive compression pressure.
Air entrapment within the tablet during ejection can also contribute by causing the tablet to expand suddenly, leading to stress and cracking. Additionally, deep concave punches and worn or damaged tooling can exacerbate the problem by creating uneven stresses. Cracking may be worsened by brittle excipients or coating stresses and can sometimes be visible only under close inspection.
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
6. Binding
Definition: Binding occurs when tablets stick, seize, or tear within the die, impeding ejection and potentially causing side fractures.
This problem can lead to side fractures and deformed tablets. Binding is primarily caused by insufficient lubrication of the die, excessive moisture in the granules, excessive compression pressure, or worn and damaged tooling surfaces.
When the die walls are rough or lubrication is inadequate, the tablet adheres to the die, making ejection difficult. Additionally, excessive moisture can cause the tablet to stick, while too much compression force or limited die clearance can increase this effect.
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
7. Mottling
Definition: Mottling is characterized by uneven colour distribution on tablet surfaces, with light or dark spots appearing on an otherwise uniform surface.
This occurs primarily when the colorants or pigments are not properly mixed or evenly distributed during the formulation process. Factors contributing to mottling include the use of differently coloured ingredients, dye migration during granulation or drying, improper blending, the presence of incompatible excipients, and uneven moisture content. Mottling not only affects the tablet’s aesthetic appeal but can also indicate inconsistencies in formulation or manufacturing.
Causes:
Formulation-Related:
Remedies:
Formulation Approaches:
8. Weight Variation
Definition: Weight variation occurs when individual tablet weights fall outside acceptable pharmacopoeial limits (typically ±5% for tablets >300mg)
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
9. Hardness and Friability Problems
Definition: Hardness variation refers to inconsistent crushing strength across tablet batches. Friability measures tablet resistance to abrasion and breakage during handling, coating, packaging, and transport.
Causes:
Formulation-Related:
Machine-Related:
Remedies:
Formulation Approaches:
Machine Adjustments:
10. Double Impression
Definition: Double impression occurs when overlapping imprints appear on tablet surfaces due to punch rotation during compression.
Causes:
Remedies:
11. Blistering
Definition: Blistering of a surface film occurs when its elasticity or adhesive properties are compromised. The result is that the film becomes detached from the tablet’s substrate.
Causes:
Blistering is usually a result of high temperatures that may occur during the drying process, during the spraying stage or at the end of the coating process
Remedies:
Use mild drying conditions, and ensure moderate temperatures at other stages of the coating process.
12. Cratering
Definition: Cratering happens when a defect on the film’s coating results in craters appearing on the tablet which in turn results in the exposure of the tablet’s surface.
Causes:
Cratering can occur in certain instances where there is insufficient drying time to seal the film or a high volume of coating solution is applied. In these cases excess polymer solution can penetrate to the surface of the tablet, especially in the crown area, causing the disruption of the coating and degeneration of the tablet’s core.
Remedies:
Check the efficiency of the drying process and optimise drying conditions
13. Pitting
Definition: Pitting refers to a defect in which the tablet core undergoes deformation or indentation, even though the film coating remains intact and shows no visible damage.
Causes:
This defect arises when the temperature of the tablet core exceeds the melting point of one or more ingredients used during formulation.
Remedies:
Avoid preheating the tablets before coating begins. Adjust the drying or inlet air temperature to ensure that the tablet core temperature remains below the melting point of the formulation additives.
14. Blushing
Description: Blushing refers to the occurrence of a cloudy appearance or white specks on the film surface of a tablet.
Causes:
This defect occurs when polymer particles precipitate within the coating film, often due to an excessively high coating temperature. It can also result from polymer gelation when certain polymers are combined with incompatible materials.
Remedies:
Reduce the drying or inlet air temperature to prevent polymer precipitation. Avoid using sorbitol with polymers such as hydroxypropyl cellulose, hydroxy methyl cellulose, methyl cellulose, or other cellulose ethers.
Tablet Coating Defects
Recent comprehensive reviews have highlighted numerous coating-specific defects.
Blistering:
Film detachment due to high drying temperatures – remedy with moderate drying conditions.
Blooming:
Dull tablet appearance from plasticizer migration – adjust plasticizer concentration.
Bridging:
Coating filling logos/intagliations – reduce viscosity, increase plasticizer, improve spray atomization.
Chipping/Edge Erosion:
Film wear at tablet edges – increase film hardness, optimize pan speed, modify tablet punch design.
Orange Peel:
Rough, non-glossy surface – reduce solution viscosity, use gentler drying conditions.
Picking (coating):
Material adherence in coating – ensure proper granule drying and lubrication.
Colour Variation:
Inconsistent coating colour – modify spray equipment, adjust spray rate.
CONCLUSION:
Tablet manufacturing defects remain a significant challenge in pharmaceutical production despite technological advances. Recent literature emphasizes that successful defect prevention requires a multifaceted approach integrating optimized formulation design, precise machine control, environmental regulation, and comprehensive quality assurance systems.
Key strategies emerging from recent research include:
The pharmaceutical industry's continued focus on innovation, coupled with stringent regulatory oversight and adoption of emerging technologies, provides a pathway toward producing consistently high-quality, defect-free tablets that ensure patient safety and therapeutic efficacy. Future developments in artificial intelligence, continuous manufacturing, and personalized medicine will further transform tablet manufacturing, enabling more robust processes and superior product quality.
REFERENCES
Sofiya Pathan, Asmita Ingale, Vidya Kapse, Dr. V. M. Dharashive, A Review Article on Tablet Defects and Their Remedies, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 12, 3406-3418. https://doi.org/10.5281/zenodo.18022168
10.5281/zenodo.18022168